Empowering the global health care community
We believe we have a vital role in providing needed support and fostering wellness for those dealing with serious medical conditions. This belief anchors all that we do and sharpens our singular focus on the people we help, not just the medical conditions they deal with—from the development of therapies that positively impact the lives of millions worldwide, to our advocacy involvement to generate a deeper understanding of these disorders. Patients are at the center of everything we do.
Developing a robust pipeline of potential new therapies
We have a strong pipeline of investigational medicines in various stages of development for psychiatric, neurological, respiratory and other disorders with unmet needs. In addition, we are leveraging new drug delivery methods and evolving technology, such as computational chemistry approaches, the power of big data and brain imaging, as well as new digital health solutions.
Delivering important therapies for serious medical conditions
Sunovion's track record of discovery, development and commercialization of important therapies includes Brovana® (arformoterol tartrate), Latuda® (lurasidone HCl), and Aptiom® (eslicarbazepine acetate). Approved therapies also include Utibron® Neohaler® (indacaterol and glycopyrrolate) Inhalation Powder, Seebri® Neohaler® (glycopyrrolate) Inhalation Powder, Arcapta® Neohaler® (indacaterol) Inhalation Powder and Lonhala® Magnair® (glycopyrrolate) Inhalation Solution.
Acting with compassion and responsibility
Sunovion has a commitment to work with partners to support the local, regional and global community as part of our overall Corporate Social Responsibility efforts. Collaboration helps in meaningful ways to build stronger communities where our employees live and work, a passion shared by our people.